Insufficient scRNA-seq data for expression of HAPLN4 at single-cell level.
Insufficient scRNA-seq data for expression of HAPLN4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 98% | 1068.67 | 221 / 226 | 0% | 0 | 0 / 406 |
brain | 93% | 1892.58 | 2465 / 2642 | 0% | 0 | 0 / 705 |
prostate | 48% | 99.23 | 118 / 245 | 0% | 0 | 0 / 502 |
ovary | 47% | 65.37 | 85 / 180 | 0% | 0 | 0 / 430 |
kidney | 44% | 64.43 | 39 / 89 | 0% | 0 | 0 / 901 |
uterus | 43% | 110.91 | 73 / 170 | 0% | 0 | 0 / 459 |
adrenal gland | 20% | 48.06 | 51 / 258 | 0% | 0 | 0 / 230 |
intestine | 18% | 350.92 | 178 / 966 | 0% | 0 | 0 / 527 |
lung | 14% | 12.21 | 81 / 578 | 0% | 0 | 0 / 1155 |
breast | 13% | 15.07 | 60 / 459 | 0% | 0 | 0 / 1118 |
pancreas | 10% | 10.15 | 33 / 328 | 0% | 0 | 0 / 178 |
blood vessel | 9% | 8.81 | 126 / 1335 | 0% | 0 | 0 / 0 |
stomach | 5% | 5.08 | 17 / 359 | 0% | 0 | 0 / 286 |
adipose | 5% | 6.51 | 56 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 1% | 1.60 | 20 / 1445 | 0% | 0 | 0 / 183 |
heart | 1% | 1.02 | 8 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.90 | 1 / 241 | 0% | 0 | 0 / 0 |
skin | 0% | 0.19 | 3 / 1809 | 0% | 0 | 0 / 472 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0001501 | Biological process | skeletal system development |
GO_0010001 | Biological process | glial cell differentiation |
GO_0051932 | Biological process | synaptic transmission, GABAergic |
GO_1904862 | Biological process | inhibitory synapse assembly |
GO_0007155 | Biological process | cell adhesion |
GO_0007417 | Biological process | central nervous system development |
GO_0005615 | Cellular component | extracellular space |
GO_0045202 | Cellular component | synapse |
GO_0072534 | Cellular component | perineuronal net |
GO_0150043 | Molecular function | structural constituent of synapse-associated extracellular matrix |
GO_0005540 | Molecular function | hyaluronic acid binding |
Gene name | HAPLN4 |
Protein name | Hyaluronan and proteoglycan link protein 4 (Brain link protein 2) |
Synonyms | BRAL2 KIAA1926 |
Description | FUNCTION: Essential for the proper localization of brevican (BCAN), mainly as a perineuronal nets (PNNs)-type deposition in the brainstem and cerebellum thereby playing a key role in the formation and structural organization of PNNs (By similarity). Contributes to the formation and transmission of inhibitory GABAergic synapses between Purkinje cells and deep cerebellar nuclei neurons (By similarity). . |
Accessions | Q86UW8 ENST00000291481.8 |